Argenx is spending $2.2 billion to…
Argenx is spending $2.2 billion to absorb Forte Biosciences for [...]
Argenx is spending $2.2 billion to absorb Forte Biosciences for [...]
AstraZeneca executives told Fierce they are “very confident” in the [...]
Amgen has laid off around 40 employees as part of [...]
Sanofi has abandoned plans to seek approval for amlitelimab in [...]
In vivo gene editing outfit Scribe Therapeutics has priced its [...]
AI-focused Formation Bio has found a new chief scientist with [...]
Scancell and Neuphoria have made their union official via a [...]
Eli Lilly’s triple-G drug retatrutide has hit the primary endpoints [...]
Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the [...]
Roche may have scrapped work on a T-cell engager being [...]